Top

Gepubliceerd in:

01-07-2005 | Artikel

Mond- en slikklachten in de palliatieve fase

Auteurs: E. J. M. de Nijs, E. H. Verhagen

Gepubliceerd in: Bijblijven | Uitgave 7/2005

Samenvatting

Bij patiënten in de palliatieve fase kunnen door de ziekte en/of de behandeling veranderingen in de mond optreden. Deze veranderingen geven klachten die grote invloed kunnen hebben op de kwaliteit van leven. Ze kunnen leiden tot veranderingen in de voedingstoestand van de patiënt en problemen veroorzaken met intimiteit en sociale contacten.mondproblemen slikstoornissen palliatieve zorg

vorige artikel Mondklachten door systeemziekten en geneesmiddelengebruik

Nieweg RMB. Mondproblemen bij chemotherapie: verandering van het mondslijmvlies. Verpleegkundige probleemgebieden: Diagnoses & Interventies 1995;1(12-1):1-30.

Sbanotto A. Oral complications of cancer. In: Ripamonti C, Bruera E. Gastrointestinal symptoms in advanced cancer patients. Oxford: Oxford University Press.; 2002. p. 81-113.

Swart EL, Waal I van der, Wilhelm AJ. Orale bijwerkingen van geneesmiddelen. Geneesmiddelenbulletin 2001;35:133-7.

Velthuizen L, Lugt-Lustig K de, Nieweg R. Mondverzorging: Anatomie, fysiologie, pathologie en optimale mondhygiëne. TvZ/vakblad voor verpleegkundigen 1993;20:659-66.

Velthuizen L, Lugt-Lustig K de, Nieweg R. Vijf protocollen voor mondverzorging. TvZ/vakblad voor verpleegkundigen 1993:21:720-4.

Vissink A, Spijkervet FKL, Stegenga B. Geneesmiddelen bij aandoeningen van mond, gebit en kaak. Geneesmiddelenbulletin 2001;35:119-26.

Alves MB, Motta AC, Messina WC, Migliari DA. Saliva substitute in xerostomic patients with primary Sjogren’s syndrome: A single-blind trial. Quintessence Int 2004;35:392-6.PubMed

Björnström M, Axell T, Birkhed D. Comparison between saliva stimulants and saliva substitutes in patients with symptoms related to dry mouth: A multi-centre study. Swed Dent J 1990;14:153-61.PubMed

Davies AN. Management of xerostomia: A review. Eur J Cancer Care 1997;6:209-14.CrossRef

Davies AN AN, Daniels C, Pugh R, Sharma K. A comparison of artificial saliva and pilocarpine in the management of xerostomia in patients with advanced cancer. Palliat Med 1998;12:105-11.CrossRef

Davies AN. A comparison of artificial saliva and chewing gum in the management of xerostomia in patients with advanced cancer. Palliat Med 2000;14:197-203.CrossRefPubMed

Davies AN, Broadley K, Beighton D. Xerostomia in patients with advanced cancer. J Pain Symptom Manage 2001;22:820-5.CrossRefPubMed

Dodd MJ, Larson PJ, Dibble SL et al. Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy. Oncol Nurs Forum 1996;23:921-7.PubMed

Epstein JB, Emerton S, Le ND, Stevenson-Moore P. A double-blind crossover of Oral Balance gel and Biotene toothpaste versus placebo in patients with xerostomia following radiation therapy. Oral Oncol 1999;35:132-7.CrossRefPubMed

Freer SK. Use of an oral assessment tool to improve practice. Prof Nurse 2000;15:635-7.PubMed

Guchelaar HJ, Vermes A, Meerwalt JH. Radiation-induced xerostomia: Pathophysiology, clinical course and supportive treatment. Support Care Cancer 1997;5;281-8.CrossRefPubMed

Hawthorne M, Sullivan K. Pilocarpine for radiation-induced xerostomia in head and neck cancer. Int J Palliat Nurs 2000;l:228-32.

Holmes S. Xerostomia: etiology and management in cancer patients. Support Care Cancer 1998;6:348-355.CrossRefPubMed

Jobbins J. A clinical trial of chlorhexidine oral spray in terminally ill cancer patients. Palliat Med 1992;6:299-307.CrossRef

Nieuw Amerongen AV, Veerman ECI. Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Support Care Cancer 2003;11:226-31.PubMed

Oneschuk D, Hanson J, Bruera E. A survey of mouth pain and dryness in patients with advanced cancer. Support Care Cancer 2000;8:372-6.CrossRefPubMed

Regelink G, Vissink A, Reintsema H, Nauta JM. Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostomia. Quintessence Int 1998;29:383-6.PubMed

Sreebny LM, Valdini A, Yu A. Xerostomia. Part I: relationship to other oral symptoms and salivary gland hypofunction. Oral Surgery, Oral Medicine and Oral Pathology 1988;66:451-8.CrossRef

Sreebny LM, Valdini A, Yu A. Xerostomia. Part II: relationship to nonoral symptoms, drugs and diseases. Oral Surgery, Oral Medicine and Oral Pathology 1989;68:419-27CrossRef

Stone P, A’Hern R. Artificial saliva versus pilocarpine for xerostomia. Palliat Med 1999;13:81-2.CrossRefPubMed

Sweeney MP, Bagg J, Baxter WP et al. Clinical trial of a mucin-containing oral spray for treatment of xerostomia in cancer patients. Palliat Med 1997;11:225-32.CrossRefPubMed

Vissink A, ’s-Gravenmade EJ, Panders AK et al. A clinical comparison between commercially available mucin- and CMC-containing saliva substitutes. International Journal of Oral Surgery 1983;12:232-8.CrossRefPubMed

White ID, Hoskin PJ, Hanks GW et al. Morphine and dryness of mouth. BMJ 1989;298:203-7.CrossRef

Carvalho MD, Tabchoury CM, Cury JA, Toledo S, Nogueira-Filho G. Impact of mouth rinses on morning bad breath in healthy subjects. J Clin Periodontol 2004;21:85-90.CrossRef

Louis J, Moyer J, Angelini J, et al. Metronidazole oral rinse helps to alleviate odor associated with oral lesions. Oncol Nurs Forum 1997;24:1331.PubMed

Ru VJ de, Spronsen R van. Onaangename lichaamsgeuren. III Foetor ex ore. Ned Tijdschr Geneeskd 1986;130:955-7.PubMed

Scully C, Porter S, Greenman J. What to do about halitosis. BMJ 1994;308:217-8.PubMed

Soder B, Johansson B, Soder PO. The relation between foetor ex ore, oral hygiene and periodontal disease. Swed Dent J 2000;24:73-82.PubMed

Winkel EG, Roldan S, Winkelhoff AJ van, et al. Clinical effects of a new mouthrinse containing chlorhexidine, cetylpyridinium chloride and zinc-lactate on oral halitosis. A dual-center, double-blind placebo-controlled study. J Clin Periodontol 2003;30:300-6.CrossRefPubMed

Borowski B, Benhamou E, Pico Jl. Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: A randomized controlled trial comparing two protocols of dental care. European Journal of Cancer, Oral Oncology 1994;30B:93-7CrossRef

Cha R, Sobel JD. Fluconazole for the treatment of candidiasis: 15 year experience. Expert Review of Anti-infective Therapy 2004;2:357-66.CrossRefPubMed

Chiara S, Nobile MT, Vincenti M, et al. Sucralfate in the treatment of chemotherapy-induced stomatitis: A double-blind placebo-controlled trial. Anticancer Res 2001;21:3707-10.PubMed

Clarkson JE, Worthington HV, Eden OB. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews 2003, issue 3.

Karis K, Kwong F. Prevention and treatment of oropharyngal mucositis following cancer therapy. Cancer Nurs 2004;27:183-205CrossRef

Loprinzi CL, Ghosh C, Camoriano J et al. Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy. J Clin Oncol 1997;15:1235-8.PubMed

Meredith R, Saklter M, Kim R et al. Sucralfate for radiation mucositis: Results of a double-blind randomized trial. Int J Radiat Oncol Biol Phys 1997;37:275-9.PubMed

Shieh SH, Wang ST, Tsai ST, Tseng CC. Mouth care for nasopharngeal cancer patients undergoing radiotherapy. Oral Oncol 1997;33:93-7.CrossRef

Trotti A, Bellm LA, Epstein JB et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiother Oncol 2003; 66: 253-62.CrossRefPubMed

Uitterhoeve RJ. Richtlijn verhoogd risico op beschadigd mondslijmvlies: Richtlijn beschadigd mondslijmvlies. Landelijke Oncologische Verpleegkundige Richtlijnen, patroon 2.4; 2000.

Vissink A, Burlage FR, Spijkervet FKL, et al. Prevention and treatment of the consequences of head and neck radiotherapy. Critical Review of Oral Biology Medicine 2003;14:213-55.CrossRef

Wothington H, Clarkson JE, Eden OB. Interventions treating oral mucositis for patients with cancer receiving treatment [review]. Cochrane library 2005;(1).

Titel: Mond- en slikklachten in de palliatieve fase
Auteurs: E. J. M. de Nijs
E. H. Verhagen
Publicatiedatum: 01-07-2005
Uitgeverij: Bohn Stafleu van Loghum
Gepubliceerd in: Bijblijven / Uitgave 7/2005
Print ISSN: 0168-9428
Elektronisch ISSN: 1876-4916
DOI: https://doi.org/10.1007/BF03059874

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen

Andere artikelen Uitgave 7/2005

Slikstoornissen en voedingsproblemen bij ouderen

Mondklachten door systeemziekten en geneesmiddelengebruik

Zwellingen in de mond; van speekselsteen tot carcinoom

Enkele niet-infectieuze aandoeningen van mond, lippen en tong

Infecties van het mondslijmvlies

Redactioneel ten geleide